Beijing Tide Pharmaceutical Co., Ltd.
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Subsidiary
- Established
- 1995-05-29
- Employees
- -
- Market Cap
- -
- Website
- https://www.tidepharm.com
Clinical Trials
10
Active:0
Completed:1
Trial Phases
3 Phases
Phase 1:3
Phase 2:3
Not Applicable:4
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (10 trials with phase data)• Click on a phase to view related trials
Not Applicable
4 (40.0%)Phase 1
3 (30.0%)Phase 2
3 (30.0%)To Evaluate the Efficacy and Safety of TRD205 Tablets in the Treatment of Chronic Postoperative Neuralgia
Not Applicable
- Conditions
- Chronic Postoperative Neuralgia
- Interventions
- Drug: TRD205 tabletsDrug: Placebo
- First Posted Date
- 2025-08-14
- Last Posted Date
- 2025-08-17
- Lead Sponsor
- Beijing Tide Pharmaceutical Co., Ltd
- Target Recruit Count
- 184
- Registration Number
- NCT07123402
- Locations
- 🇨🇳
China-Japan Friendship Hospital, Beijing, China
Single and Multiple Ascending Doses and Food Effect Study of TRD205 in Healthy Volunteers
- First Posted Date
- 2025-08-14
- Last Posted Date
- 2025-08-14
- Lead Sponsor
- Beijing Tide Pharmaceutical Co., Ltd
- Target Recruit Count
- 151
- Registration Number
- NCT07123428
- Locations
- 🇨🇳
The first hospital of Jilin University, Changchun, 吉林, China
To Evaluate the Safety, Efficacy and Kinetic Characteristics of TRD205 Tablets for Postoperative Analgesia After Unilateral Hip Arthroplasty
Not Applicable
Not yet recruiting
- Conditions
- Postoperative Analgesia After Unilateral Hip Arthroplasty
- Interventions
- Drug: TRD205 tabletsDrug: placebo
- First Posted Date
- 2025-08-13
- Last Posted Date
- 2025-08-13
- Lead Sponsor
- Beijing Tide Pharmaceutical Co., Ltd
- Target Recruit Count
- 40
- Registration Number
- NCT07121101
- Locations
- 🇨🇳
The Third Affiliated Hospital of Southern Medical University, Guangzhou, Guangdong, China
To Evaluate the Safety, Efficacy and Kinetic Characteristics of TRD205 Tablets for Postoperative Analgesia After Unilateral Hallux Valgus Orthopedic Surgery
Not Applicable
Not yet recruiting
- Conditions
- Postoperative Analgesia After Unilateral Hallux Valgus Correction Surgery
- Interventions
- Drug: TRD205 tabletsDrug: Placebo
- First Posted Date
- 2025-08-13
- Last Posted Date
- 2025-08-13
- Lead Sponsor
- Beijing Tide Pharmaceutical Co., Ltd
- Target Recruit Count
- 32
- Registration Number
- NCT07121023
- Locations
- 🇨🇳
Beijing Jishuitan Hosapital, Beijing, Beijing, China
A Phase Ib/II Clinical Study in Patients With Refractory Chronic Cough
Phase 1
Not yet recruiting
- Conditions
- Refractory Chronic Cough
- Interventions
- Drug: TCR1672 tablet
- First Posted Date
- 2024-01-19
- Last Posted Date
- 2024-01-19
- Lead Sponsor
- Beijing Tide Pharmaceutical Co., Ltd
- Target Recruit Count
- 72
- Registration Number
- NCT06213363
- Prev
- 1
- 2
- Next
News
Beijing Tide's First-in-Class AT2R Antagonist TRD205 Enters Phase II Trials for Chronic Post-Surgical Pain
Beijing Tide Pharmaceutical has dosed the first patient in Phase II trials of TRD205, a first-in-class AT2R antagonist targeting chronic post-surgical neuropathic pain without opioid-related risks.